ClinConnect ClinConnect Logo
Search / Trial NCT07036211

Transmission of Oncogenic HPV Infection Among Families

Launched by TAMPERE UNIVERSITY HOSPITAL · Jun 16, 2025

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Oropharyngeal Cancer Cervical Cancer Hpv

ClinConnect Summary

This study is looking at how certain types of human papillomavirus (HPV) that can lead to cancers—like cervical cancer and some head and neck cancers—are passed between family members. Researchers want to learn more about how HPV spreads between sexual partners and from parents to their children. They will also explore how other microbes (tiny organisms like bacteria) might affect how long HPV infections last and how likely they are to cause cancer.

The study will include up to 300 couples from clinics in Finland, along with their children who are over 12 years old. Eligible participants are people who have a long-lasting HPV infection, cervical cancer, or HPV-related head and neck cancer, as well as their partners and children. Those taking part will provide samples from their mouth and private areas themselves, several times over up to five years. They will also fill out questionnaires about their health, habits, and environment. The information gathered will help improve HPV screening and prevention, and may identify new signs that increase cancer risk. This study is not yet enrolling participants, and you need to speak Finnish to take part.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient with colposcopy clinic detected persisting HR-HPV infection
  • Patient with diagnosed cervical cancer
  • Patient with diagnosed OSCC
  • Patients' sexual partners of women or men that are referred to the colposcopy/gynecological oncology/ENT
  • offspring (over 12 years old) of the referred couples
  • Exclusion Criteria:
  • Candidate who don't speak Finnish

About Tampere University Hospital

Tampere University Hospital (TAYS) is a leading academic medical center in Finland, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, TAYS integrates cutting-edge medical practices with rigorous scientific investigation, focusing on improving patient outcomes and enhancing treatment modalities across various specialties. The hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to foster a multidisciplinary approach to medical research, ensuring that findings are translated into real-world applications for the benefit of patients and the broader healthcare community.

Locations

Kuopio, , Finland

Tampere, , Finland

Patients applied

0 patients applied

Trial Officials

Karolina Louvanto, Professor

Principal Investigator

Tampere University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported